ODYY (Odyssey Health) EPS (Basic) : $-0.16 (TTM As of Jan. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Odyssey Health EPS (Basic)?

Odyssey Health's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.16.

Odyssey Health's EPS (Diluted) for the three months ended in Jan. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.16.

Odyssey Health's EPS without NRI for the three months ended in Jan. 2025 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was -0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Odyssey Health EPS (Basic) Historical Data

The historical data trend for Odyssey Health's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Health EPS (Basic) Chart

Odyssey Health Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

EPS (Basic)

Get a 7-Day Free Trial

-0.05

-0.18

-0.09

-0.07

-0.01

Odyssey Health Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EPS (Basic)	Get a 7-Day Free Trial															0.14	-0.01	-0.14	-0.01	-

Odyssey Health EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Odyssey Health's Basic EPS for the fiscal year that ended in Jul. 2024 is calculated as

Basic EPS (A: Jul. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.842	-	0)	/	97.064
	=	-0.01

Odyssey Health's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.22	-	0)	/	104.710
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.16

Odyssey Health (OTCPK:ODYY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Odyssey Health EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Odyssey Health's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Odyssey Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Health Inc (OTCPK:ODYY) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102

Website

https://www.odysseyhealthinc.com

Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.

Executives

Erik C. Emerson	other: Chief Commercial Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda	other: Chief Operating Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson	director	2372 MORSE AVE., IRVINE CA 92614
Christine Farrell	officer: Controller/Secretary	2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey	director	2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy	director	2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d	director	2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond	director, officer: President/CEO	10 CANTERBURY ROAD, WINDHAM NH 03087